Showing 41 - 60 results of 16,731 for search '(((( 50 ms decrease ) OR ( 50 ((ng decrease) OR (a decrease)) ))) OR ( 100 ng decrease ))', query time: 0.56s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44

    Bioinformatics analysis of the gene pathways that were enriched in the N.g MDP–treated osteocytes and verification <i>in vitro</i>. by Zheng-Rong Gao (12488388)

    Published 2022
    “…Green arrow, BMSCs; blue arrow, osteoblast; red arrow, osteocyte; Control, the sample was treated with culture medium in vitro or saline only in vivo; MDP, the sample was treated with 1 μg/ml N.g MDP for 36 h in vitro or 2 μg N.g MDP dissolved in 100 μl of saline solution for 10 days in vivo.…”
  5. 45
  6. 46
  7. 47
  8. 48
  9. 49
  10. 50

    Data-Driven Tool for Cross-Run Ion Selection and Peak-Picking in Quantitative Proteomics with Data-Independent Acquisition LC–MS/MS by Binjun Yan (17310633)

    Published 2023
    “…Proteomics provides molecular bases of biology and disease, and liquid chromatography–tandem mass spectrometry (LC–MS/MS) is a platform widely used for bottom-up proteomics. …”
  11. 51
  12. 52
  13. 53
  14. 54
  15. 55
  16. 56
  17. 57

    Trial profile. by Chanel Avenant (409756)

    Published 2024
    “…Both contraceptives substantially decreased, from D0 to 25W, the total testosterone [DMPA-IM D0 0.560, 25W 0.423 nmol/L, -24.3% (p < 0.0001); NET-EN D0 0.551, 25W 0.253 nmol/L, -54.1%, (p < 0.0001)], SHBG [DMPA-IM D0 45.0, 25W 32.7 nmol/L, -29.8% (p < 0.0001); NET-EN D0 50.2, 25W 17.6 nmol/L, -65.1% (p < 0.0001)], and calculated free testosterone levels [DMPA-IM D0 6.87, 25W 5.38 pmol/L, -17.2% (p = 0.0371); NET-EN D0 6.00, 25W 3.70, -40.0% (p < 0.0001)]. …”
  18. 58
  19. 59
  20. 60